Skip to content

GI Cancer Icon Changing outcomes for people with GIgastro-intestinal cancer since 1991

Donate Now
  • Make a Single Gift
  • Give a Monthly Gift
  • Give In Memory
  • A Gift In Your Will
  • Fundraise For Us
MENUMENU
  • Home
  • About
    • About Us
      • Chair’s Message
      • Board of Directors
      • Staff Members
      • Governance
      • Employment Opportunities
      • Our impact
      • Annual Reports
      • Scientific Advisory Committee
      • Community Advisory Panel
      • International Development Committee
      • Translational Research Committee
      • New Zealand Committee
      • Research Operations Committee
      • Upper GI and Lower GI Working Parties
      • Corporate Support
  • GI Cancer
    • What is GI cancer?
      • Oesophageal Cancer
      • Liver Cancer
      • Stomach Cancer
      • Gallbladder & Biliary Tract Cancer
      • Pancreatic Cancer
      • Gastro-Intestinal Stromal Tumour (GIST)
      • Neuroendocrine Tumours (NETs)
      • Colorectal Cancer
      • Rectal Cancer
      • Small Bowel Cancer
      • Anal Cancer
    • Resources
      • Videos
      • Webinars
      • Cancer FAQ
      • Support Groups
      • Recommended Reading
      • Information Booklets
      • Recipes
      • Helpful Links
      • Newsletter Sign-up
    • News
      • Stories
      • Community Forums
  • Trials & Research
    • Clinical Trials
      • Trial Recruitment
      • Concepts - In Development
      • Trials - In Development
      • Trials - Open
      • Trials - In Follow-up
      • Trials - Completed
      • Trials - Substudies
      • Trials - Endorsed Studies
      • Participating Trial Centres
      • Clinical Trial FAQs
      • Genesis of a Clinical Trial
    • Research
      • Developing our Research
      • Research Priorities
      • Upper GI and Lower GI Working Parties
      • Idea Generation Workshop
      • Endorsed Study Model
      • Translational Research
      • Translational Research Model
      • Tele-Trial Model
      • Publications and Presentations
  • Health Professionals
    • AGITG
      • Become a Member
      • Member Spotlight
      • Our impact
      • Funding
    • Awards and Grants
      • Innovation Grant
      • Rectal Cancer Research Grant
      • Philanthropic Funding
      • Merck-AGITG Clinical Research Fellowship in GI Cancer
      • New Concepts Symposium
      • Best of Posters & Fast Forward
      • Outstanding Site Award
      • John Zalcberg OAM Award
      • Christine Aiken Memorial Award for Excellence in AGITG Study Coordination
      • AGITG Member Fundraiser of the Year Award
      • Grant Opportunities
      • Early Career Research Award for Excellence in AGITG Research
    • CommNETs
      • Presentations & Publications
      • Projects & Working Groups
      • Newsletters
      • Annual Research Workshop
      • CommNETs Committees
      • CommNETs Committee
      • Preceptorships
      • Policies
      • Contacts
    • News
      • Events & Education
        • Annual Scientific Meeting
  • ASM
  • Get Involved
    • The Gutsy Challenge
      • 2023 Gutsy Challenge Adventures
      • Blue Mountains Gutsy Challenge 2023
      • Past Gutsy Challenge Adventures
    • Fundraise
      • Start a Gutsy Fundraiser
      • Walk, Run or Ride for Research
      • Raise Your Fork for Research
      • Create Your Own Event
      • Workplace Fundraising Ideas
    • Donate
      • Where Does My Gift Go?
      • Make a Single Gift
      • Give a Monthly Gift
      • Direct Deposit Donation
      • A Gift In Your Will
      • Give In Memory
      • Workplace Giving
    • Volunteer
      • Corporate Support
  • Contact
  • Newsletter Sign-up
  • Member Login
Clinical Trials Benefit Rare Cancer Patients

Donations

Thanks to a clinical trial, Sarah McGoram survived 20 years beyond a Gastro-Intestinal Stromal Tumour (GIST) diagnosis that gave her 18 months to live

Make a Single Gift

Monthly Gift

Direct Deposit

Donate

Donating to clinical trials enables real benefit to be realised by real people — including immediate benefit for the people who take part. Any donation, no matter what size, will help us to conduct our clinical trials and lead to better health outcomes for the 33,200 Australian patients diagnosed with GI cancer each year.

Or you can pledge your support as a regular giving partner, providing the financial stability that allows us to plan for the future.

Donations over $2.00 are tax-deductible. A tax receipt will be issued on receipt of your donation.

Donate Online

To make a one-off donation or to set up a regular donation using your credit card, please click here.


Direct Deposit

To make a direct deposit donation using your bank account, please click here.
You will then receive a confirmation email with your unique reference details to make a direct deposit donation.


Over the phone donations

Please call us on 1300 666 769, during business hours (Monday to Friday, 9am to 5pm).


Donate via email

Please contact us via email to donations@gicancer.org.au. Be sure to include your name and contact details as well as your payment details.


Fundraise

Please contact us via email to donations

Contact melanie@gicancer.org.au if you are interested in fundraising for GI Cancer research. You can take on a Gutsy Challenge or set up a Community Fundraiser. Either way we are here to help so please contact us to find out more


We can also help you if you are looking to set up the following;

  • In Memory gift or fundraising page – click here for more,
  • a bequest in your Will – click here for more, or
  • Workplace giving – click here for more.
Share

Clinical trials: real people, real benefits

GI Cancer Institute clinical trials are about bringing real benefit to real people — including immediate benefit for the people who take part.

Since 1991, our trials have helped save and extend lives, and improve the quality of life for people with GI cancers.

Many people taking part in trials have told us how they’ve appreciated the high standard of care and access to the latest treatments, and very importantly the chance to be an active participant in their own treatment, work with their medical team, and learn more about their cancer and its treatment.

Sarah McGoram (pictured with husband Tom) has survived far beyond expectations, almost twenty years beyond a diagnosis of Gastro-Intestinal Stromal Tumour (GIST) that gave her eighteen months to live.

“The trials gave me access to drugs I wouldn’t otherwise have had access to”, says Sarah.

“And better information. The support from the medical team was invaluable — I was apprehensive at first but they explained clearly the pros and cons. It took a lot of pressure off and gave me a tremendous sense of hope.”

And Tom adds: “The more you engage with a science-based approach to treatment, the more you understand about your own condition and have opportunities to get the drug or treatment you need to help manage it.”

Dr Peter Grimison, a medical oncologist who collaborates with the AGITG on several trials, agrees: “Clinical trials are an extremely important way to make medical progress in cancer, particularly for rare cancers which are difficult to treat.

“Making trials available to my patients allows them access to new treatments that could be life-saving, but are otherwise unavailable or unaffordable.”

Even people whose prognosis is very poor can find comfort in being able to help others.

“People are sitting in front of me who are dying and we don’t have anything to help them”, says Dr Lorraine Chantrill, Principal Investigator on AGITG’s IMPACT trial on pancreatic cancer.

“When we tell them ‘I don’t have a new treatment but I do have an investigational trial – do you want to participate and help future patients?’ they jump at the opportunity.”

Among other achievements, AGITG clinical trials have improved life expectancy for people with gastro-intestinal stromal tumour (GIST) by over 500%, and those with select pancreatic cancer types by 30%. Clinical Trials have proven that for people with oesophageal cancer, adding chemotherapy and radiation therapy before surgery significantly improves survival rates; and identified a specific gene likely to respond to a particular type of chemotherapy, which means improving the treatment for bowel cancer.

If you have a GI cancer (or are supporting someone who does), ask your doctor about whether there might be an AGITG clinical trial suitable for you.

You can also help the AGITG continue its research and clinical trials by donating here today.

© Copyright AGITG 2017 Privacy Terms and Conditions

Registered Charity
Gastro Intestinal Cancer Institute Logo
  • Home
  • About
    • About Us
      • Chair’s Message
      • Board of Directors
      • Staff Members
      • Governance
      • Employment Opportunities
      • Our impact
      • Annual Reports
      • Scientific Advisory Committee
      • Community Advisory Panel
      • International Development Committee
      • Translational Research Committee
      • New Zealand Committee
      • Research Operations Committee
      • Upper GI and Lower GI Working Parties
      • Corporate Support
  • GI Cancer
    • What is GI cancer?
      • Oesophageal Cancer
      • Liver Cancer
      • Stomach Cancer
      • Gallbladder & Biliary Tract Cancer
      • Pancreatic Cancer
      • Gastro-Intestinal Stromal Tumour (GIST)
      • Neuroendocrine Tumours (NETs)
      • Colorectal Cancer
      • Rectal Cancer
      • Small Bowel Cancer
      • Anal Cancer
    • Resources
      • Videos
      • Webinars
      • Cancer FAQ
      • Support Groups
      • Recommended Reading
      • Information Booklets
      • Recipes
      • Helpful Links
      • Newsletter Sign-up
    • News
      • Stories
    • Engage
      • Community Forums
  • Trials & Research
    • Clinical Trials
      • Trial Recruitment
      • Concepts – In Development
      • Trials – In Development
      • Trials – Open
      • Trials – In Follow-up
      • Trials – Completed
      • Trials – Substudies
      • Trials – Endorsed Studies
      • Participating Trial Centres
      • Clinical Trial FAQs
      • Genesis of a Clinical Trial
    • Research
      • Developing our Research
      • Research Priorities
      • Upper GI and Lower GI Working Parties
      • Idea Generation Workshop
      • Endorsed Study Model
      • Translational Research
      • Translational Research Model
      • Tele-Trial Model
      • Publications and Presentations
  • Health Professionals
    • AGITG
      • Become a Member
      • Member Spotlight
      • Our impact
      • Funding
    • Awards and Grants
      • Innovation Grant
      • Rectal Cancer Research Grant
      • Philanthropic Funding
      • Merck-AGITG Clinical Research Fellowship in GI Cancer
      • New Concepts Symposium
      • Best of Posters & Fast Forward
      • Outstanding Site Award
      • John Zalcberg OAM Award
      • Christine Aiken Memorial Award for Excellence in AGITG Study Coordination
      • AGITG Member Fundraiser of the Year Award
      • Grant Opportunities
      • Early Career Research Award for Excellence in AGITG Research
    • CommNETs
      • Presentations & Publications
      • Projects & Working Groups
      • Newsletters
      • Annual Research Workshop
      • CommNETs Committees
      • CommNETs Committee
      • Preceptorships
      • Policies
      • Contacts
    • News
      • Events & Education
        • Annual Scientific Meeting
  • ASM
  • Get Involved
    • The Gutsy Challenge
      • 2023 Gutsy Challenge Adventures
      • Blue Mountains Gutsy Challenge 2023
      • Mt Himlung Himal Ascent – Nepal 2021
      • Past Gutsy Challenge Adventures
    • Fundraise
      • Start a Gutsy Fundraiser
      • Walk, Run or Ride for Research
      • Raise Your Fork for Research
      • Create Your Own Event
      • Workplace Fundraising Ideas
    • Donate
      • Where Does My Gift Go?
      • Make a Single Gift
      • Give a Monthly Gift
      • Direct Deposit Donation
      • A Gift In Your Will
      • Give In Memory
      • Workplace Giving
    • Volunteer
      • Corporate Support
  • Contact

GI Cancer Icon Changing outcomes for people with GIgastro-intestinal cancer since 1991

Donate Now